The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart disease, Parkinson’s, sleep apnea and addiction.

For the roughly 4,300 people in the study who used semaglutide — the ingredient in Ozempic and Wegovy — there were about 220 hospitalizations for alcohol use disorder. Others in the study were taking older GLP-1 drugs, including liraglutide and ...